Revive Therapeutics Announces Filing of FDA Pre-IND Meeting

TORONTO, April 03, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV),…

Roadman Investments Signs Definitive Agreement with Psychedelic Insights Solidifying Psychedelics Clinic Investment

March 31, 2020 – TheNewswire – VANCOUVER, British Columbia – Roadman Investments Corp. (TSXV:LITT) (FWB:1QD) (OTC:RMANF) (“Roadman Investments” or the…

Revive Therapeutics Provides Corporate Update on its COVID-19 and Infectious Diseases Programs

Revive Therapeutics Ltd. (CSE: RVV) TORONTO, March 30, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive”…

Revive Therapeutics Engages Pharma-Olam and Strengthens Infectious Diseases Clinical Development Team to Advance U.S. FDA Clinical Study for COVID-19

Revive Therapeutics Ltd. (CSE: RVV) TORONTO, March 25, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive”…

Champignon Brands appoints Dr.Joseph Gabrielle, Ernst & Young 2018 Health care entrepreneur of the year and delivera™ inventor to special advisory committee

Champignon Brands Inc. (CSE: SHRM) (FWB: 496) (OTC: SHRMF) VANCOUVER, British Columbia, March 25, 2020 (GLOBE…

Revive Therapeutics Appoints Dr. David Boulware, MD, as Scientific Advisor for Infectious Diseases including COVID-19

Revive Therapeutics Ltd. (CSE: RVV) TORONTO, March 24, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive”…

RVV | A penny stock that may have an Influenza / Covid-19 treatment in its hands ?

For several weeks, the world has been upside down due to the rapid spread of a…

Champignon brands announces normal course issuer bid for common shares of the corporation

VANCOUVER, British Columbia, March 20, 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (“Champignon” or the “Company”) (CSE:…

Champignon brands expands alternative medicine IP portfolio with ketamine, adaptogenic delivery systems/formulations

VANCOUVER, British Columbia, March 19, 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (“Champignon” or the “Company”) (CSE:…

Revive Announces Closing of the Acquisition of Psilocin Pharma Corp.

TORONTO, March 05, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”), a company…

Mind Medicine Inc goes public on the psychedelics market

Mind Medicine Inc., a psychedelics-based medicine startup closed a $24.2 million funding before to go public…

Yield Growth to Enter Booming Market with Immunity-Boosting Mushroom Products

Vancouver, British Columbia–(Newsfile Corp. – February 27, 2020) –  The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE:YG3)…